Feldan Therapeutics

About

Feldan Therapeutics has developed a patented peptide-based technology platform.

Quebec,Quebec,Canada
11 - 50

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $2M
Industries: Biotechnology,Therapeutics
Founded date: Jan 1, 2007
Number Of Employee: 11 - 50
Operating Status: Active

Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$15.80M

Feldan Therapeutics has raised a total of $15.80M in funding over 2 rounds. Their latest funding was raised on Jan 18, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 18, 2022	Grant	—	1	—	—	Detail
Oct 12, 2018	Grant	$2M	1	National Institutes of Health	—	Detail
Sep 18, 2018	Series A	$13.80M	4	GC	—	Detail
Sep 28, 2011	Seed	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

8

Feldan Therapeutics is funded by 8 investors. National Institutes of Health and GC are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institutes of Health	Yes	Grant
GC	Yes	Series A
Cystic Fibrosis Foundation	—	Grant
AQC Capital	—	Series A
Asahi Kasei Corporate Venture Capital	—	Series A
Stonebridge Ventures	—	Series A
FIER Succes	—	Seed
Anges Quebec	—	Seed